Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCCAP.L Regulatory News (CCAP)

  • There is currently no data for CCAP

Appointment

13 Oct 2006 07:01

Charlemagne Capital Limited13 October 2006 13 October 2006 Charlemagne Capital Charlemagne Capital appoints Vicky Kydoniefs as Head of Consultant Relationships Charlemagne Capital Limited, the specialist emerging markets equity investmentmanagement group, is pleased to announce the appointment of Vicky Kydoniefs asHead of Consultant Relationships. Vicky has extensive experience in the institutional investment management field.Before joining Charlemagne Capital, she was with Merrill Lynch InvestmentManagers ("MLIM") in London for 12 years, most recently as Head of UK & IrishInstitutional Business Development. Prior to that she was in charge of thecompany's relationships and sales effort with a number of key consultant firms.Vicky started her career in 1986 with SG Warburg, whose investment managementbusiness was subsequently acquired by MLIM. Julian Mayo, Investment Director commented: "Vicky is widely respected in the pension fund and broader institutional marketplace, an area of increasing importance to Charlemagne Capital. Much of thisbusiness is driven by consultants, an area where she is particularly strong.Vicky will also help us establish best practice in pitching for institutionalbusiness and is an important addition to our team." Enquiries: Charlemagne Capital Tel. 020 7518 2100Julian Mayo, Investment Director Smithfield Consultants Tel. 020 7360 4900John KielyGeorge Hudson Notes to Editors: Charlemagne Capital is a specialist emerging markets equity investmentmanagement group. Charlemagne Capital Limited was admitted to the AIM market ofthe London Stock Exchange on 4 April 2006. Charlemagne's product range comprises mutual funds, hedge funds andinstitutional and specialist fund products primarily covering GEMs, EasternEurope, Latin America and Asia. Charlemagne Capital employs a range ofinvestment strategies including: long only, long/short, structured products andprivate equity. Charlemagne Capital's funds aim to exploit the inefficiencies inthe market via a strict bottom up approach and focused stock selection. Through the strong long-term investment performance track record of itsprincipal funds, Charlemagne Capital has established itself as a market leaderin emerging markets investment management. Its performance has been recognisedthrough numerous awards and top rankings for its funds, including the 2005Standard and Poor's 5-year best performing fund award in Austria, the 2006 SwissLipper Leaders 5-year award winner for Emerging Markets Europe and an AAA-ratingby Standard & Poor's for its Magna Eastern European Fund (a sub-fund of MagnaUmbrella Fund Plc). This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
15th Sep 20082:33 pmRNSDirector/PDMR Shareholding
15th Sep 200810:25 amRNSHolding(s) in Company
11th Sep 20087:00 amRNSTransaction in Own Shares
8th Sep 20087:00 amRNSTransaction in Own Shares
5th Sep 20087:00 amRNSTransaction in Own Shares
4th Sep 20081:49 pmRNSViewing Interim Financial Sta
3rd Sep 20087:01 amRNSDividend Declaration
3rd Sep 20087:00 amRNSInterim Results
14th Aug 20087:00 amRNSNotice of Results
13th Aug 20087:00 amRNSDividend Election Procedure
11th Jul 20087:00 amRNSHalf Year Trading Statement
18th Jun 20087:00 amRNSAnnual Report and Interim Res
27th May 20087:00 amRNSLaunch of New Fund
7th May 200812:32 pmRNSResult of AGM
7th May 20089:13 amRNSAGM Statement
15th Apr 20089:20 amRNSDirector/PDMR Shareholding
15th Apr 20087:00 amRNSDirector/PDMR Shareholding
11th Apr 200811:19 amRNSDirector/PDMR Shareholding
9th Apr 20087:00 amRNSStatement re Q1 AuM Update
28th Mar 200810:03 amRNSDirector/PDMR Shareholding
19th Mar 20081:38 pmRNSDirector/PDMR Shareholding
6th Mar 20083:39 pmRNSHolding(s) in Company
4th Mar 20085:38 pmRNSTransaction in Own Shares
27th Feb 20084:38 pmRNSDirectorate Change
27th Feb 20084:34 pmRNSHolding(s) in Company
27th Feb 20087:01 amRNSDividend Declaration
27th Feb 20087:01 amRNSFinal Results
15th Feb 20085:22 pmRNSHolding(s) in Company
7th Feb 20085:02 pmRNSHolding(s) in Company
7th Feb 200812:25 pmRNSHolding(s) in Company
31st Jan 20085:37 pmRNSHolding(s) in Company
25th Jan 20087:00 amRNSNotice of Final Results
15th Jan 20083:08 pmRNSHolding(s) in Company
10th Jan 20087:00 amRNSTrading Statement
9th Jan 20087:00 amBUSHolding(s) in Company
2nd Jan 20084:42 pmRNSHolding(s) in Company
10th Dec 20079:23 amRNSDirector/PDMR Shareholding
10th Dec 20079:19 amRNSHolding(s) in Company
30th Nov 20077:35 amRNSTransaction in Own Shares
21st Nov 20075:48 pmRNSTransaction in Own Shares
19th Nov 20075:37 pmRNSTransaction in Own Shares
16th Nov 20075:36 pmRNSTransaction in Own Shares
14th Nov 20077:01 amRNSE. European OCCO Fund Closes
6th Nov 20075:24 pmRNSTransaction in Own Shares
17th Oct 20077:00 amRNSTransaction in Own Shares
15th Oct 20077:01 amRNSTransaction in Own Shares
4th Oct 20077:01 amRNSAssets under Manage
4th Oct 20077:01 amRNSTransaction in Own Shares
19th Sep 20075:58 pmRNSTransaction in Own Shares
17th Sep 20075:15 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.